{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:04:48Z","timestamp":1792040688839,"version":"4.4.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Advanced medical Nutrition","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Epilepsy is a common treatable neurological condition characterized by recurrent involuntary brain activity manifested in seizures. It is estimated that around 30% of patients with this disease do not respond to initial pharmacological treatments, developing drug-resistant epilepsy. Among the non-pharmacological treatment options are ketogenic diet therapies (KDT) in its various forms. The objective of this study is to systematically review the randomized controlled trials investigating the use of KDTs in pediatric and adult drug-resistant epilepsy, according to Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. The following databases: Embase, PubMed\/Medline, LILACS, and the Cochrane Library, were searched and studies fitting the inclusion and exclusion criteria were included for analysis. Randomized controlled trials (RCT) with a minimum follow-up of 28 days were included. There were 1193 articles retrieved after duplicates were removed and 17 met the inclusion criteria. Eleven studies included children (up to 12 yrs) and six included adolescents from 13 years old and adults. Follow-up ranged from 6 to 24 months. In children, 37% may achieve a reduction in seizure frequency of 50% or more with in any form of KDT (moderate-certainty evidence). In addition, about 6 more children per 100 may achieve a\u2009\u2265\u200990% reduction, although this is supported by low-certainty evidence. In adolescents and adults, KDT may lead to a\u2009\u2265\u200950% reduction in seizure frequency in 16 more individuals per 100 compared with usual care (moderate-certainty evidence), but its impact on a 90% or greater reduction is uncertain due to the limited number of reported events and imprecision in available studies. Side effects in children showed no significant differences compared to usual care (low certainty), while in adults, the impact remains uncertain (very low certainty). Adherence to treatment may be slightly lower with KDT in both children and adults\/adolescents compared to usual treatment, though results are inconsistent. Regarding quality of life and cognitive and behavioral outcomes, studies are scarce, heterogeneous, and of very low certainty, limiting the ability to draw strong conclusions.<\/jats:p>","DOI":"10.1371\/journal.pone.0333334","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:57:17Z","timestamp":1783015037000},"page":"e0333334","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ketogenic diet therapies for the treatment of drug-resistant epilepsy in children and adults: A systematic review"],"prefix":"10.1371","volume":"21","author":[{"given":"Mar\u00eda Magdalena","family":"Vaccarezza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Laura","family":"Sanguine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-2485","authenticated-orcid":true,"given":"Giselle","family":"Balaciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"13","key":"pone.0333334.ref001","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"BS Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0333334.ref002","volume-title":"Epilepsy: frequency, causes, and consequences","author":"WADCH Hauser","year":"1990"},{"issue":"12","key":"pone.0333334.ref003","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1586\/ern.09.114","article-title":"Management of the patient with medically refractory epilepsy","volume":"9","author":"T Granata","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"pone.0333334.ref004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"P Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"pone.0333334.ref005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"EH Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"issue":"5","key":"pone.0333334.ref006","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","article-title":"A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy","volume":"50","author":"EG Neal","year":"2009","journal-title":"Epilepsia"},{"issue":"5","key":"pone.0333334.ref007","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1203\/00006450-197605000-00006","article-title":"Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy","volume":"10","author":"PR Huttenlocher","year":"1976","journal-title":"Pediatr Res"},{"issue":"1","key":"pone.0333334.ref008","first-page":"56","article-title":"Recommendations for the clinical management of children with refractory epilepsy receiving the ketogenic diet","volume":"114","author":"MJ Alberti","year":"2016","journal-title":"Arch Argent Pediatr"},{"issue":"1","key":"pone.0333334.ref009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"M Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"4","key":"pone.0333334.ref010","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1528-1167.2012.03406.x","article-title":"E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective","volume":"53","author":"MC Cervenka","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"pone.0333334.ref011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1528-1167.2006.00438.x","article-title":"A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy","volume":"47","author":"EH Kossoff","year":"2006","journal-title":"Epilepsia"},{"issue":"11","key":"pone.0333334.ref012","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/01.wnl.0000187071.24292.9e","article-title":"Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy","volume":"65","author":"HH Pfeifer","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"pone.0333334.ref013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","article-title":"Anticonvulsant mechanisms of the ketogenic diet","volume":"48","author":"KJ Bough","year":"2007","journal-title":"Epilepsia"},{"issue":"9","key":"pone.0333334.ref014","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.21037\/tp-23-211","article-title":"Effect of a ketogenic diet on decrease of seizures in refractory epilepsy among children (infancy to 14 years old) in Saudi Arabia: a cross-sectional study","volume":"12","author":"LR Baghdadi","year":"2023","journal-title":"Transl Pediatr"},{"key":"pone.0333334.ref015","doi-asserted-by":"crossref","first-page":"110683","DOI":"10.1016\/j.yebeh.2025.110683","article-title":"Over twenty-five years of ketogenic diet therapy: Supporting children and adults with drug-resistant epilepsy using nutritionally complete ketogenic formulations: A scoping review","volume":"172","author":"JH Carroll","year":"2025","journal-title":"Epilepsy Behav"},{"issue":"6","key":"pone.0333334.ref016","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/epi.16543","article-title":"Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis","volume":"61","author":"L Lyons","year":"2020","journal-title":"Epilepsia"},{"issue":"6","key":"pone.0333334.ref017","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"KJ Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0333334.ref018","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pone.0333334.ref019","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7653","key":"pone.0333334.ref020","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"HJ Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"pone.0333334.ref021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/epi4.12308","article-title":"Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy","volume":"4","author":"K Borges","year":"2019","journal-title":"Epilepsia Open"},{"issue":"10","key":"pone.0333334.ref022","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1080\/1028415X.2021.1927604","article-title":"The effect of ketogenic diet escalation in adolescents and adults with drug-resistant epilepsy: a prospective study","volume":"25","author":"NA Kishk","year":"2022","journal-title":"Nutr Neurosci"},{"issue":"8","key":"pone.0333334.ref023","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/epi.14457","article-title":"Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial","volume":"59","author":"M Kverneland","year":"2018","journal-title":"Epilepsia"},{"issue":"5","key":"pone.0333334.ref024","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17585","article-title":"Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial","volume":"64","author":"M Kverneland","year":"2023","journal-title":"Epilepsia"},{"issue":"13","key":"pone.0333334.ref025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000206776","article-title":"Safety, Efficacy, and Tolerability of Modified Atkins Diet in Persons With Drug-Resistant Epilepsy: A Randomized Controlled Trial","volume":"100","author":"M Manral","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"pone.0333334.ref026","first-page":"72","article-title":"Modified Atkins diet in adult with refractory epilepsy: A controlled randomized clinical trial","volume":"16","author":"M Zare","year":"2017","journal-title":"Iran J Neurol"},{"key":"pone.0333334.ref027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2022.10.015","article-title":"Modified Atkins diet versus levetiracetam for non-surgical drug-resistant epilepsy in children: A randomized open-label study","volume":"103","author":"Archna, Garg D, Goel S, Mukherjee SB, Pemde HK, Jain P, et al","year":"2022","journal-title":"Seizure"},{"issue":"3","key":"pone.0333334.ref028","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/epi.14679","article-title":"Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial","volume":"60","author":"A Dressler","year":"2019","journal-title":"Epilepsia"},{"issue":"6","key":"pone.0333334.ref029","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ane.12137","article-title":"Modified Atkins diet vs classic ketogenic formula in intractable epilepsy","volume":"128","author":"OF El-Rashidy","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"pone.0333334.ref030","doi-asserted-by":"crossref","first-page":"880944","DOI":"10.3389\/fneur.2022.880944","article-title":"Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease With Epilepsy: A Prospective, Open-labeled, Controlled Study","volume":"13","author":"L Huang","year":"2022","journal-title":"Front Neurol"},{"key":"pone.0333334.ref031","doi-asserted-by":"crossref","first-page":"106574","DOI":"10.1016\/j.eplepsyres.2021.106574","article-title":"Efficacy of low glycemic index diet therapy (LGIT) in children aged 2-8 years with drug-resistant epilepsy: A randomized controlled trial","volume":"171","author":"K Lakshminarayanan","year":"2021","journal-title":"Epilepsy Res"},{"issue":"2","key":"pone.0333334.ref032","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/ane.12592","article-title":"A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy","volume":"135","author":"DAJE Lambrechts","year":"2017","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"pone.0333334.ref033","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"EG Neal","year":"2008","journal-title":"Lancet Neurol"},{"issue":"12","key":"pone.0333334.ref034","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S1474-4422(23)00370-8","article-title":"Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial","volume":"22","author":"NE Schoeler","year":"2023","journal-title":"Lancet Neurol"},{"key":"pone.0333334.ref035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eplepsyres.2016.09.002","article-title":"Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: A randomized controlled trial","volume":"127","author":"S Sharma","year":"2016","journal-title":"Epilepsy Res"},{"issue":"8","key":"pone.0333334.ref036","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/08830738211004747","article-title":"Evaluation of the Modified Atkins Diet for the Treatment of Epileptic Spasms Refractory to Hormonal Therapy: A Randomized Controlled Trial","volume":"36","author":"S Sharma","year":"2021","journal-title":"J Child Neurol"},{"issue":"3","key":"pone.0333334.ref037","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/epi.12069","article-title":"Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial","volume":"54","author":"S Sharma","year":"2013","journal-title":"Epilepsia"},{"issue":"12","key":"pone.0333334.ref038","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00134-024-07660-9","article-title":"Set reliable hypotheses when using ICEMAN to assess the credibility of subgroup analysis","volume":"50","author":"M Liu","year":"2024","journal-title":"Intensive Care Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:57:24Z","timestamp":1783015044000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333334"}},"subtitle":[],"editor":[{"given":"Sidra Kaleem","family":"Jafri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333334","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}